BRCA2 and triple-negative breast carcinoma: In this study, no oncogenic variants are detected in BRCA2 gene however variants of uncertain significance are identified in two individuals of triple negative breast cancer, one case with family history of cancer and the other one has not (rs587781399, rs431825354), and a VUS in high grade serous carcinoma with family history of thyroid cancer (rs80359254).